发明授权
US08901149B2 Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications
有权
咪唑并[1,2-a]吡啶衍生物：制备和药物应用
![Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications](/docs/US/2014-12-02/US08901149B2/abs.jpg.600x600.jpg)
- 专利标题： Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications
- 专利标题（中）： 咪唑并[1,2-a]吡啶衍生物：制备和药物应用
-
申请号： US14147290申请日： 2014-01-03
-
公开(公告)号： US08901149B2公开(公告)日： 2014-12-02
- 发明人: Ken Chi Lik Lee , Eric T. Sun , Haishan Wang
- 申请人： MEI Pharma, Inc.
- 申请人地址： US CA San Diego
- 专利权人： MEI Pharma, Inc.
- 当前专利权人： MEI Pharma, Inc.
- 当前专利权人地址： US CA San Diego
- 代理机构： Wilson Sonsini Goodrich & Rosati
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; A61K31/44 ; C07D498/02 ; C07D491/02
![Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications](/abs-image/US/2014/12/02/US08901149B2/abs.jpg.150x150.jpg)
摘要：
The present invention relates to hydroxamate compounds which are inhibitors of histone deacetylase. More particularly, the present invention relates to imidazo[1,2-a]pyridine containing compounds and methods for their preparation. These compounds may be useful as medicaments for the treatment of proliferative disorders as well as other diseases involving, relating to or associated with enzymes having histone deacetylase activities (HDAC).
公开/授权文献
信息查询
